Document is current
Any future updates will be listed below
-
Authors
Lebughe Litite, P http://orcid.org/0000-0002-4984-0452
Westhovens, R. http://orcid.org/0000-0002-3432-3073
Nkodila, A. http://orcid.org/0000-0002-1403-8451
Malemba, J. J. http://orcid.org/0000-0001-7716-2882
de Vlam, K. http://orcid.org/0000-0003-3848-5122
-
Funding
Funding for this research was provided by:
Vervenne Fund KULeuven
- License Information
-
More Information
Article History
Received: 29 June 2022
Accepted: 6 June 2023
First Online: 21 June 2023
Declarations
:
: The study received ethical approval from the National Ethics Committee (Comité national de bioéthique, Democratic Republic of Congo) (ESP/CE/014/2016). All patient or their legal gardians give informed consent for participation in the study All methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.The datasets generated and analysed during the current study are not publicly available. They will be provided in an anonymised way on simple request after submission of a written request and approval of the National Ethics Committee. Comité national de bioéthique, Democratic Republic of Congo). Request can be sent to following contact: kurt.devlam@uzleuven.be.
: PLL is the recipient of the Marc Vervenne Fund (2017–2018). KdV received honoraria and consulting payments from Eli Lilly, UCB, Amgen, AbbVie. RW has nothing to declare. AN has nothing to declare. JJM has nothing to declare.
